Description
Tirzepatide is used to manage type 2 diabetes, treat chronic obesity, and address obstructive sleep apnea (OSA) in adults. It is a dual GIP and GLP-1 receptor agonist that works by mimicking two natural gut hormones to regulate blood sugar, delay stomach emptying, and reduce appetite. Tirzepatide is a single molecule that activates the body’s receptors for GIP and GLP-1, which are natural incretin hormones. Both GIP and GLP-1 receptors are found in areas of the human brain important for appetite regulation. Tirzepatide has been shown to decrease food intake and modulate fat utilization.
How It Works
Tirzepatide is often referred to as a “twincretin” because of its dual action.
- Insulin Regulation: It triggers the pancreas to release more insulin when blood sugar levels rise and lowers glucagon secretion.
- Digestion Delay: It slows down gastric emptying, keeping food in the stomach longer to signal fullness.
- Brain Signaling: It acts directly on appetite receptors in the brain to significantly lower food cravings and “food noise”.
Appearance: White
Cas No: 2023788-19-2
Molecular Formula: C225H348N48O68
Physical State: Lyophilized Powder
